Sido Muncul Overview
- Year Founded
-
1951

- Status
-
Public
- Employees
-
3,589

- Stock Symbol
-
SIDO

- Investments
-
1
- Share Price
-
$0.04
- (As of Friday Closing)
Sido Muncul General Information
Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.
Contact Information
Website
www.sidomuncul.co.idCorporate Office
- Tentrem Hotel Building Jalan Legian Gajahmada No. 123
- 1st Floor
- Semarang, 50134
- Indonesia
Corporate Office
- Tentrem Hotel Building Jalan Legian Gajahmada No. 123
- 1st Floor
- Semarang, 50134
- Indonesia
Sido Muncul Stock Performance
As of 14-Feb-2025, Sido Muncul’s stock price is $0.04. Its current market cap is $1.15B with 30B shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.04 | $0.04 | $0.03 - $0.05 | $1.15B | 30B | 14.5M |
Sido Muncul Financials Summary
As of 30-Sep-2024, Sido Muncul has a trailing 12-month revenue of $242M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 1,274,823 | 958,685 | 1,392,855 | 1,744,086 |
Revenue | 242,044 | 233,743 | 260,022 | 279,977 |
EBITDA | 96,624 | 84,850 | 100,117 | 116,316 |
Net Income | 72,158 | 62,314 | 74,311 | 87,795 |
Total Assets | 260,652 | 249,165 | 262,339 | 284,567 |
Total Debt | 218 | 601 | 153 | 606 |
Sido Muncul Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sido Muncul Signals
Sido Muncul Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Sido Muncul Acquisitions (1)
Sido Muncul’s most recent deal was a Merger/Acquisition with PT. Berlico Mulia Farma. The deal was made on 01-Sep-2014.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
PT. Berlico Mulia Farma | 01-Sep-2014 | Merger/Acquisition | Pharmaceuticals |
Sido Muncul ESG
Risk Overview
Risk Rating
Updated January, 28, 2025
21.68 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile

Pharmaceuticals
Industry
of 853
Rank
Percentile

Pharmaceuticals
Subindustry
of 425
Rank
Percentile

Sido Muncul FAQs
-
When was Sido Muncul founded?
Sido Muncul was founded in 1951.
-
Where is Sido Muncul headquartered?
Sido Muncul is headquartered in Semarang, Indonesia.
-
What is the size of Sido Muncul?
Sido Muncul has 3,589 total employees.
-
What industry is Sido Muncul in?
Sido Muncul’s primary industry is Pharmaceuticals.
-
Is Sido Muncul a private or public company?
Sido Muncul is a Public company.
-
What is Sido Muncul’s stock symbol?
The ticker symbol for Sido Muncul is SIDO.
-
What is the current stock price of Sido Muncul?
As of 14-Feb-2025 the stock price of Sido Muncul is $0.04.
-
What is the current market cap of Sido Muncul?
The current market capitalization of Sido Muncul is $1.15B.
-
What is Sido Muncul’s current revenue?
The trailing twelve month revenue for Sido Muncul is $242M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »